Company Filing History:
Years Active: 2018-2022
Title: Chien-Cheng Tseng: Innovator in Cancer Treatment
Introduction
Chien-Cheng Tseng is a prominent inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 8 patents, Tseng's work focuses on genomic targeting techniques that aim to improve patient outcomes in cancer therapy.
Latest Patents
One of Tseng's latest patents is titled "Methods of treating cells containing fusion genes by genomic targeting." This invention relates to methods for treating patients with cancer or premalignant conditions. It is based on the discovery that a genome editing technique specifically targeting a fusion gene can induce cell death in various cancer cells, including hepatocellular cancer cells. The methods provided in this patent aim to produce an anti-cancer effect by targeting fusion genes present within the cells of a subject.
Another significant patent by Tseng is "Methods for predicting prostate cancer relapse." This invention outlines methods for determining whether a subject with prostate cancer is at an increased risk for relapse or rapid relapse. The method is based on a comprehensive genome analysis of 273 prostate cancer samples, indicating that the percentage of large size copy number variations (CNVs) can predict prostate cancer relapse. By determining the number and size of CNVs in a sample, healthcare providers can assess a patient's risk for relapse.
Career Highlights
Chien-Cheng Tseng is affiliated with the University of Pittsburgh, where he conducts his research and develops his innovative methods. His work has garnered attention in the medical community, particularly for its potential to enhance cancer treatment strategies.
Collaborations
Tseng collaborates with notable colleagues, including Jianhua Luo and Joel Byron Nelson, who contribute to his research efforts and advancements in cancer treatment methodologies.
Conclusion
Chien-Cheng Tseng's contributions to cancer treatment through his patented methods highlight his role as an innovator in the field. His research not only advances scientific understanding but also holds promise for improving patient care in oncology.